SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Fermenta Biotech informs about non-applicability of large corporate entity

29 Apr 2025 Evaluate

In connection with SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018, SEBI/HO/DDHS/P/CIR/2021/613 dated August 10, 2021 (updated as on April 13, 2022) and in connection with BSE circular LIST/COMP/05/2019-20 dated April 11, 2019, BSE Circular No. LIST/COMP/59/2019-20 dated March 3, 2020 and BSE Notice No. 20220427-2 dated April 27, 2022 (‘Circulars’), Fermenta Biotech has informed that the company is not a ‘Large Corporate’ (as defined in the Circulars) as per the financial statements as on March 31, 2025. The company has attached the relevant declarations in Annexure A and Annexure B2.

The above information is a part of company’s filings submitted to BSE.

Fermenta Biotech Share Price

311.55 -1.00 (-0.32%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×